Given the substantial variability in the age at which MTC develops, even among individuals with the same RET mutation in the same family, it is generally accepted that the timing of PTT should be determined based on results for integrated RET testing and b/sCtn levels (1, 2, 45, 68) (Table 1, Figure 2). Here, RET is linked to medullary thyroid gland carcinoma.